Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Claudia Adams Barr Program in Innovative Basic Cancer Research at Dana-Farber Cancer Institute is widely recognized as one of the largest and most successful programs of its kind. Based on a rigorous and highly selective process, the Claudia Adams
Barr Program selects the brightest, most creative scientists and funds their most innovative ideas to propel basic research discoveries that transform cancer treatment. Claudia Adams Barr Program investigators have made tremendous advances and spearheaded
breakthroughs that are improving care, quality of life, and survival for patients everywhere.
The Dana-Farber Marathon Challenge directs 100 percent of funds raised to Dana-Farber Cancer Institute's Claudia Adams Barr Program in Innovative Basic Cancer Research. The program enables scientists at the leading edge of discovery to achieve better
cure rates and to enhance patients' quality of life.
Here are brief descriptions of
selected projects supported by the Barr Program, illustrating some of the program's most significant impacts to date.